Experience in the Treatment of Male Prolactinomas: A Single-Center, 10-Year Retrospective Study

被引:0
作者
Ke, Xiaoan [1 ]
Chen, Xiaoxue [1 ]
Wang, Linjie [1 ]
Duan, Lian [1 ]
Yang, Hongbo [1 ]
Yao, Yong [2 ]
Deng, Kan [2 ]
Pan, Hui [1 ]
Gong, Fengying [1 ]
Zhu, Huijuan [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Key Lab Endocrinol, Natl Hlth Commiss, Dept Endocrinol,State Key Lab Complex Severe & Rar, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Neurosurg, Beijing, Peoples R China
关键词
Male; Prolactinoma; Surgery; Medication; Multidisciplinary treatment; CLINICAL CHARACTERISTICS; MEN; BROMOCRIPTINE; CABERGOLINE; HYPERPROLACTINEMIA; MANAGEMENT; DIAGNOSIS; OUTCOMES; THERAPY;
D O I
10.1159/000541495
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Male prolactinomas are uncommon and typically macroadenomas with difficult treatment and management. The purpose of this study was to summarize the treatment and management experiences of 254 male prolactinoma patients at a single center. Methods: This was a 10-year retrospective study conducted at a single center. A total of 254 male prolactinoma patients were included. Clinical data for all subjects were collected using an electronic medical record system. Results: A total of 254 male patients with prolactinoma were studied. Their median age at onset was 28.8 years, and median disease duration was 28.5 months. The median PRL levels were 582.0 ng/mL at diagnosis. Their median maximum tumor diameter was 23.0 mm, with macroadenoma accounting for the majority (76.7%). After treatment, the biochemical remission rate with monotherapy was 36.6%, but significantly increased to 60.6% with multidisciplinary treatment (p < 0.001). Knosp 0-2 patients had significantly higher rates of biochemical remission compared to Knosp 3-4 (all p < 0.05). In addition, the maximum diameter of adenoma (B = -0.110, p = 0.008) and cavernous sinus invasion (B = -1.741, p = 0.023) were negatively correlated with postoperative biochemical remission. The maximum diameter of the adenoma (B = - 0.131, p < 0.001) was a negative correlation factor, while treatment duration (B = 0.034, p = 0.002) was a positive correlation factor for biochemical response to medication. Conclusion: Male prolactinoma has a low biochemical remission rate when treated alone, but multitherapy can improve it even more. Surgery may also be considered for male prolactinoma with a micro, and noninvasive tumor after a thorough evaluation.
引用
收藏
页码:1077 / 1089
页数:13
相关论文
共 41 条
[1]   The role of endoscopic endonasal surgery in the management of prolactinomas based on their invasiveness into the cavernous sinus [J].
Abou-Al-Shaar, Hussam ;
Mallela, Arka N. ;
Patel, Aneek ;
Shariff, Rimsha K. ;
Shin, Samuel S. ;
Choi, Phillip A. ;
Faraji, Amir H. ;
Fazeli, Pouneh K. ;
Costacou, Tina ;
Wang, Eric W. ;
Fernandez-Miranda, Juan C. ;
Snyderman, Carl H. ;
Gardner, Paul A. ;
Zenonos, Georgios A. .
PITUITARY, 2022, 25 (03) :508-519
[2]   Long-Term Follow-Up of Primary Medical Versus Surgical Treatment of Prolactinomas in Men: Effects on Hyperprolactinemia, Hypogonadism, and Bone Health [J].
Andereggen, Lukas ;
Frey, Janine ;
Andres, Robert H. ;
El-Koussy, Marwan ;
Beck, Jurgen ;
Seiler, Rolf W. ;
Christ, Emanuel .
WORLD NEUROSURGERY, 2017, 97 :595-602
[3]   Long-term outcome of multimodal therapy for giant prolactinomas [J].
Andujar-Plata, Paula ;
Villar-Taibo, Rocio ;
Dolores Ballesteros-Pomar, Maria ;
Vidal-Casariego, Alfonso ;
Perez-Corral, Begona ;
Manuel Cabezas-Agricola, Jose ;
Alvarez-Vazquez, Paula ;
Serramito, Ramon ;
Bernabeu, Ignacio .
ENDOCRINE, 2017, 55 (01) :240-247
[4]   Approach to the Patient With Prolactinoma [J].
Auriemma, Renata S. ;
Pirchio, Rosa ;
Pivonello, Claudia ;
Garifalos, Francesco ;
Colao, Annamaria ;
Pivonello, Rosario .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (09) :2400-2423
[5]   PROLACTINOMA IN 53 MEN - CLINICAL CHARACTERISTICS AND MODES OF TREATMENT (MALE PROLACTINOMA) [J].
BEREZIN, M ;
SHIMON, I ;
HADANI, M .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1995, 18 (06) :436-441
[6]   Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline [J].
Bhasin, Shalender ;
Cunningham, Glenn R. ;
Hayes, Frances J. ;
Matsumoto, Alvin M. ;
Snyder, Peter J. ;
Swerdloff, Ronald S. ;
Montori, Victor M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (06) :2536-2559
[7]   Prolactinomas in male and female patients: A comparative clinicopathologic study [J].
Calle-Rodrigue, RDP ;
Giannini, C ;
Scheithauer, BW ;
Lloyd, RV ;
Wollan, PC ;
Kovacs, KT ;
Stefaneanu, L ;
Ebright, AB ;
Abboud, CF ;
Davis, DH .
MAYO CLINIC PROCEEDINGS, 1998, 73 (11) :1046-1052
[8]   Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors [J].
Cozzi, Renato ;
Ambrosio, Maria Rosaria ;
Attanasio, Roberto ;
Battista, Claudia ;
Bozzao, Alessandro ;
Caputo, Marco ;
Ciccarelli, Enrica ;
De Marinis, Laura ;
De Menis, Ernesto ;
Fustini, Marco Faustini ;
Grimaldi, Franco ;
Lania, Andrea ;
Lasio, Giovanni ;
Logoluso, Francesco ;
Losa, Marco ;
Maffei, Pietro ;
Milani, Davide ;
Poggi, Maurizio ;
Zini, Michele ;
Katznelson, Laurence ;
Luger, Anton ;
Poiana, Catalina .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2022, 186 (03) :P1-P33
[9]   Sex-related difference in the growth of prolactinomas: A clinical and proliferation marker study [J].
Delgrange, E ;
Trouillas, J ;
Maiter, D ;
Donckier, J ;
Tourniaire, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07) :2102-2107
[10]   Central Diabetes Insipidus in Infancy With or Without Hypothalamic Adipsic Hypernatremia Syndrome: Early Identification and Outcome [J].
Djermane, Adel ;
Elmaleh, Monique ;
Simon, Dominique ;
Poidvin, Amelie ;
Carel, Jean-Claude ;
Leger, Juliane .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (02) :635-643